Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization [0.03%]
住院期间优化射血分数降低的心力衰竭患者指南指导的药物治疗
Neal M Dixit,Shivani Shah,Boback Ziaeian et al.
Neal M Dixit et al.
Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients w...
Trevor J Simard,Mackram F Eleid
Trevor J Simard
Tricuspid regurgitation (TR) adversely impacts both quality of life and long-term survival, which generates interest in therapeutic approaches to mitigate these effects. Historically, therapeutic options for TR were limited to surgical appr...
Rediscovered and Unforgotten: Transcatheter Interventions for the Treatment of Severe Tricuspid Valve Regurgitation [0.03%]
重获重视而未被遗忘的治疗方法——经导管三尖瓣反流介入治疗
Kusha Rahgozar,Sharon Bruoha,Edwin Ho et al.
Kusha Rahgozar et al.
Tricuspid valve regurgitation is both globally prevalent and undertreated. Historically, surgical intervention for isolated tricuspid regurgitation (TR) was avoided despite the prevalence of TR, largely due to poor surgical outcomes and an ...
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation [0.03%]
接受长期抗凝治疗的冠状动脉复杂经皮介入患者的抗血栓治疗
Despoina-Rafailia Benetou,Panayotis K Vlachakis,Charalampos Varlamos et al.
Despoina-Rafailia Benetou et al.
The optimal antithrombotic treatment in patients receiving oral anticoagulation undergoing percutaneous coronary intervention (PCI) has been a field of intensive research. Although triple antithrombotic therapy had been, until lately, the s...
Alex F Warren,Carolyn Rosner,Raghav Gattani et al.
Alex F Warren et al.
The mortality of cardiogenic shock (CS) remains unacceptably high. Delays in the recognition of CS and access to disease-modifying or hemodynamically stabilizing interventions likely contribute to poor outcomes. In parallel to successful in...
Andrea Elliott,Garima Dahyia,Rajat Kalra et al.
Andrea Elliott et al.
The rising incidence and recognition of cardiogenic shock has led to an increase in the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO). As clinical experience with this therapy has increased, there has also been a rapid ...
Advances in Transcatheter Electrosurgery for Treating Valvular Heart Disease [0.03%]
经导管射频消融治疗瓣膜性心脏病的进展
Jaffar M Khan,Toby Rogers,Adam B Greenbaum et al.
Jaffar M Khan et al.
Delivery of electrosurgery energy through catheters and guidewires enables interventionists to 'cut' through obstructive intravascular lesions or across cardiac chambers. A novel application of transcatheter electrosurgery is to make contro...
Effect of Operator Experience on Transcatheter Mitral Valve Repair Outcomes [0.03%]
术者经验对经导管主动脉瓣置换效果的影响
Justin P Sheehy,Adnan K Chhatriwalla
Justin P Sheehy
Transcatheter mitral valve repair with MitraClip is a novel, intricate therapy for mitral regurgitation that improves survival and quality of life. Similar to other medical procedures, there is a relationship between procedural experience a...
Heart Transplant and Ventricular Assist: Cardiac Surgery and Heart Failure Perspective [0.03%]
心脏移植与左心室辅助装置植入：心脏外科和心力衰竭视角观点论文
Michael T Cain,Michael S Firstenberg,Joseph C Cleveland Jr
Michael T Cain
For nearly 60 years, there have been two surgical treatment options for individuals with severe advanced heart failure: heart transplantation or implantation of a left ventricular assist device. As these fields have advanced in parallel, im...
Platelet Function Testing and Genotyping for Tailoring Treatment in Complex PCI Patients [0.03%]
用于复杂PCI患者的个性化治疗的血小板功能检测和基因分型
Athanasios Moulias,Angeliki Papageorgiou,Dimitrios Alexopoulos
Athanasios Moulias
Dual antiplatelet therapy (DAPT), comprising aspirin and a P2Y12 receptor inhibitor, is considered the cornerstone of treatment in patients who have undergone percutaneous coronary intervention (PCI). Patients with complex PCI (C-PCI) const...